Vaccine Articles | Global Biodefense

Menu

Latest stories

Influenza virus particles

Center for Vaccine Development Awarded up to $201M to Establish Influenza Clinical Core

BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine

More on pathogens and preparedness

8th FIDSSA Congress – Federation of Infectious Diseases Societies of Southern Africa

by Global Biodefense November 7, 2019, 12:00 am
USAID Seeks Innovations in Malaria Vaccine Development

by Global Biodefense June 16, 2019, 10:53 am
Counterfeit Medications: What We Know and What Needs to be Done
CRADA Opportunity: Developing Protein Nanoparticles for the Display of Viral Epitopes

by Global Biodefense March 13, 2019, 11:23 am
Why Ebola Vaccine on Trial in DRC is Raising Hopes

by Shirin Ashraf and Arthur Wickenhagen, University of Glasgow February 10, 2019, 11:21 pm
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing

by Global Biodefense January 22, 2019, 3:26 am
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness
CDC Fiscal Year 2019 Broad Agency Announcement

by Global Biodefense December 7, 2018, 9:05 am
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine

by Global Biodefense November 15, 2018, 10:57 am
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated

by Global Biodefense November 8, 2018, 8:42 am
New Biomarkers Associated with Protection by RTS,S Malaria Vaccine
A Review of Ebola Vaccine Candidates

by Global Biodefense August 19, 2018, 3:52 pm

Congratulations. You've reached the end of the internet.

Back to Top